James Hardie Industries plc
JHX NYSE Concrete Products, Except Block & Brick Financials FY2024–FY2026
What James Hardie Industries plc does
No business description yet.
- Legal name
- James Hardie Industries plc
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K · May 19, 2026
- Accession · CIK
- 0001159152-26-000045
0001159152
Revenue and margins
James Hardie Industries plc had $4.8B of revenue in fiscal 2026, up 24.7% on the year before.
Net income and earnings per share
From fiscal 2024 to 2026, diluted EPS grew −59.5% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $206M in fiscal 2026, 4.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
James Hardie Industries plc returned $0.0M to shareholders in fiscal 2026, 0% of free cash flow. The diluted share count rose 26.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably James Hardie Industries plc can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | $416M | $563M | $269M |
| Debt incl. finance leases | — | $1.1B | $4.6B |
| Net debt / EBITDA | — | 0.6x | 4.6x |
| Debt / equity | — | 0.5x | 0.7x |
| Interest coverage | 50.2x | 63.7x | 1.9x |
| Current ratio | — | 2.1x | 1.6x |
| Quick ratio | — | 1.7x | 1.0x |
| Total assets | — | $5.2B | $13.7B |
| Total liabilities | — | $3.1B | $7.3B |
| Shareholders' equity | $1.9B | $2.2B | $6.4B |
| Net debt (− = net cash) | — | $560M | $4.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✕ |
| Current ratio rose | — | — | ✕ |
| Share count didn't rise | — | ✓ | ✕ |
| Gross margin rose | — | ✕ | ✕ |
| Revenue rose relative to assets | — | — | ✕ |
| F-score | — / 3 | — / 5 | 3 / 9 |
| Accruals ratio | — | −7.2% | −5.1% |
| Altman Z'' | — | 3.78 | 1.91 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $3.9B | $3.9B | $4.8B |
| Gross profit | $1.6B | $1.5B | $1.7B |
| Research and development | $47.0M | $48.5M | $60.7M |
| Operating income | $767M | $656M | $448M |
| Interest expense | $15.3M | $10.3M | $231M |
| Pretax income | $755M | $645M | $207M |
| Income tax | $245M | $221M | $103M |
| Net income | $510M | $424M | $104M |
| Diluted EPS | $1.16 | $0.98 | $0.19 |
| Diluted shares | 0.44B | 0.43B | 0.55B |
| Cash flow | |||
| Cash from operations | $914M | $803M | $590M |
| Capital expenditure | $449M | $422M | $384M |
| Free cash flow | $465M | $381M | $206M |
| Depreciation and amortization | $185M | $216M | $494M |
| Stock-based compensation | $28.2M | $23.0M | $38.0M |
| Acquisitions | $0.0M | $0.0M | $3.9B |
| Share buybacks | $271M | $150M | $0.0M |
| Dividends and buybacks | $271M | $150M | $0.0M |
| Balance sheet | |||
| Cash and short-term investments | $416M | $563M | $269M |
| Total debt | — | $1.1B | $4.5B |
| Finance lease liabilities | — | $3.0M | $104M |
| Current assets | — | $1.7B | $1.8B |
| Current liabilities | — | $810M | $1.2B |
| Inventory | — | $347M | $636M |
| Property and equipment, net | — | $2.2B | $3.1B |
| Goodwill | $193M | $194M | $4.8B |
| Intangible assets | — | $146M | $3.3B |
| Total assets | — | $5.2B | $13.7B |
| Total liabilities | — | $3.1B | $7.3B |
| Shareholders' equity | $1.9B | $2.2B | $6.4B |
| Margins | |||
| Gross margin | 40.4% | 38.8% | 35.8% |
| Operating margin | 19.5% | 16.9% | 9.3% |
| EBITDA margin | 24.2% | 22.5% | 19.5% |
| Net margin | 13.0% | 10.9% | 2.2% |
| FCF margin | 11.8% | 9.8% | 4.3% |
| Returns | |||
| Return on capital | — | 15.9% | 2.7% |
| Return on capital employed | — | 14.8% | 3.6% |
| Return on equity | 27.4% | 21.1% | 2.4% |
| Return on assets | — | 8.1% | 1.1% |
| Return on tangible equity | 30.6% | 23.3% | — |
| Growth | |||
| Revenue growth | — | −1.5% | 24.7% |
| Net income growth | — | −16.9% | −75.5% |
| EPS growth | — | −15.5% | −80.6% |
| FCF growth | — | −18.1% | −45.9% |
| Share count change | — | −1.7% | 26.2% |
| Financial health | |||
| Net debt / EBITDA | — | 0.6x | 4.6x |
| Debt / equity | — | 0.5x | 0.7x |
| Interest coverage | 50.2x | 63.7x | 1.9x |
| Current ratio | — | 2.1x | 1.6x |
| Quick ratio | — | 1.7x | 1.0x |
| Capital allocation | |||
| Capex / revenue | 11.4% | 10.9% | 7.9% |
| Stock comp / revenue | 0.7% | 0.6% | 0.8% |
| Payouts / FCF | 58.4% | 39.4% | 0.0% |
| Quality scores | |||
| Piotroski F-score | — | — | 3.0 |
| Altman Z'' | — | 3.8 | 1.9 |
| Accruals ratio | — | −7.2% | −5.1% |
Source: SEC EDGAR XBRL filings (CIK 0001159152). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.